Physician Breast Cancer Screening Recommendations Following Guideline Changes
Results of a National Survey
ResearchPosted on rand.org May 23, 2017Published in: JAMA Internal Medicine, [Epub April 2017]. doi:10.1001/jamainternmed.2017.0453
Physicians' recommendations for when to start and end breast cancer screening vary, depending on their level of trust with the guideline-issuing organization.
Results of a National Survey
ResearchPosted on rand.org May 23, 2017Published in: JAMA Internal Medicine, [Epub April 2017]. doi:10.1001/jamainternmed.2017.0453
Different professional societies and organizations continue to disagree over the optimal time to initiate and discontinue breast cancer screening mammography and the optimal screening interval. In October 2015, the American Cancer Society (ACS) revised its guidelines, encouraging personalized screening decisions for women ages 40 to 44 years followed by annual screening starting at age 45 years and biennial screening for women 55 years or older. The US Preventive Services Task Force (USPSTF) reissued its recommendations in January 2016 recommending personalized screening decisions for women ages 40 to 49 years followed by biennial mammograms for women ages 50 to 74 years. The American Congress of Obstetricians and Gynecologists (ACOG) recommends yearly mammograms for women 40 years or older. With physician recommendations the most important determinant for patients obtaining screening, we investigated physician recommendations in light of recent guideline changes in a national sample.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.